Market cap
$125 Mln
Revenue (TTM)
$153 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-1.5
-
Debt to Equity
0
-
Book Value
$5
-
EPS
$-2.6
-
Face value
--
-
Shares outstanding
47,293,065
9 Years Aggregate
CFO
$-245.72 Mln
EBITDA
$-296.94 Mln
Net Profit
$-356.23 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Quanterix Corp (QTRX)
| -58.5 | -28.1 | -0.4 | -42.7 | -52.6 | -44.5 | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Quanterix Corp (QTRX)
| -40.2 | -60.8 | 97.4 | -67.3 | -8.8 | 96.8 | 29.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Quanterix Corp (QTRX)
|
2.6 | 124.9 | 153.3 | -123.1 | -49.8 | -46.2 | -- | 0.5 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Quanterix Corp (QTRX)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply... Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts. Read more
-
President, CEO & Director
Dr. Masoud Toloue Ph.D.
-
President, CEO & Director
Dr. Masoud Toloue Ph.D.
-
Headquarters
Billerica, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Quanterix Corp (QTRX)
What is the current share price of Quanterix Corp (QTRX) Today?
The share price of Quanterix Corp (QTRX) is $2.64 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Quanterix Corp (QTRX) has given a return of -52.61% in the last 3 years.
What is the current PB & PE ratio of Quanterix Corp (QTRX)?
Since, TTM earnings of Quanterix Corp (QTRX) is negative, P/E ratio is not available.
The P/B ratio of Quanterix Corp (QTRX) is 0.53 times as on 28-Aug-2026, a 86 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-2.78 |
1.01 |
2024 |
-10.64 |
1.24 |
2023 |
-36.53 |
2.96 |
2022 |
-5.17 |
1.44 |
2021 |
-26.97 |
3.53 |
What is the 52 Week High and Low of Quanterix Corp (QTRX)?
The 52-week high and low of Quanterix Corp (QTRX) are Rs 8.77 and Rs 2.15 as of 31-Aug-2026.
What is the market cap of Quanterix Corp (QTRX)?
Quanterix Corp (QTRX) has a market capitalisation of $ 125 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Quanterix Corp (QTRX)?
Before investing in Quanterix Corp (QTRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.